Home › Entities › academia › Bidirectional Contrast agent leakage correction of dynamic susceptibility contrast (DSC)‐MRI improves cerebral blood volume estimation and survival prediction in recurrent glioblastoma treated with bevacizumab

Bidirectional Contrast agent leakage correction of dynamic susceptibility contrast (DSC)‐MRI improves cerebral blood volume estimation and survival prediction in recurrent glioblastoma treated with bevacizumab

Research article (Journal of Magnetic Resonance Imaging, 2016) · cited 38× · AI/ML
academia openalex:W2301275595
Press Enter · cited answer in seconds

Bidirectional Contrast agent leakage correction of dynamic susceptibility contrast (DSC)‐MRI improves cerebral blood volume estimation and survival prediction in recurrent glioblastoma treated with bevacizumab

Summary

Bidirectional Contrast agent leakage correction of dynamic susceptibility contrast (DSC)‐MRI improves cerebral blood volume estimation and survival prediction in recurrent glioblastoma treated with bevacizumab is a scholarly article[1].

Key Facts

  • Bidirectional Contrast agent leakage correction of dynamic susceptibility contrast (DSC)‐MRI improves cerebral blood volume estimation and survival prediction in recurrent glioblastoma treated with bevacizumab's instance of is recorded as scholarly article[2].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Bidirectional Contrast agent leakage correction of dynamic susceptibility contrast (DSC)‐MRI improves cerebral blood volume estimation and survival prediction in recurrent glioblastoma treated with bevacizumab. Retrieved May 24, 2026, from https://4ort.xyz/entity/bidirectional-contrast-agent-leakage-correction-of-dynamic-susceptibility-contrast-dsc-mri-improves-cerebral-blood-volum
MLA “Bidirectional Contrast agent leakage correction of dynamic susceptibility contrast (DSC)‐MRI improves cerebral blood volume estimation and survival prediction in recurrent glioblastoma treated with bevacizumab.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/bidirectional-contrast-agent-leakage-correction-of-dynamic-susceptibility-contrast-dsc-mri-improves-cerebral-blood-volum.
BibTeX @misc{4ortxyz_bidirectional-contrast-agent-leakage-correction-of-dynamic-susceptibility-contrast-dsc-mri-improves-cerebral-blood-volum_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Bidirectional Contrast agent leakage correction of dynamic susceptibility contrast (DSC)‐MRI improves cerebral blood volume estimation and survival prediction in recurrent glioblastoma treated with bevacizumab}}, year = {2026}, url = {https://4ort.xyz/entity/bidirectional-contrast-agent-leakage-correction-of-dynamic-susceptibility-contrast-dsc-mri-improves-cerebral-blood-volum}, note = {Accessed: 2026-05-24}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Bidirectional Contrast agent leakage correction of dynamic susceptibility contrast (DSC)‐MRI improves cerebral blood volume estimation and survival prediction in recurrent glioblastoma treated with bevacizumab — https://4ort.xyz/entity/bidirectional-contrast-agent-leakage-correction-of-dynamic-susceptibility-contrast-dsc-mri-improves-cerebral-blood-volum (retrieved 2026-05-24)

Canonical URL: https://4ort.xyz/entity/bidirectional-contrast-agent-leakage-correction-of-dynamic-susceptibility-contrast-dsc-mri-improves-cerebral-blood-volum · Last refreshed: